Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema - 25/08/11
, Harry W. Flynn, MD a, Carmen A. Puliafito, MD, MBA aAbstract |
Purpose |
To report pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
Design |
Retrospective, noncomparative, consecutive case series.
Methods |
Records were reviewed of all patients who developed pseudohypopyon after intravitreal triamcinolone acetonide injection at Bascom Palmer Eye Institute between January 1, 2002 and February 1, 2004.
Results |
A total of 828 intravitreal triamcinolone acetonide injections were administered to 686 patients during the study period. A pseudohypopyon (fine white crystalline opacities in the inferior anterior chamber angle) and suspended white crystalline opacities in the aqueous humor developed after 7 of the 828 injections (0.8%); all pseudohypopyons occurred within 3 days of injection and resolved completely within 2 weeks. None of the 686 patients developed clinically suspected infectious endophthalmitis.
Conclusions |
A transient pseudohypopyon may occur in the early postinjection period after intravitreal triamcinolone acetonide injection. Unless progressive intraocular inflammation occurs, close observational management is indicated.
Le texte complet de cet article est disponible en PDF. | Supported in part by Research to Prevent Blindness, Inc., New York, New York. |
Vol 138 - N° 3
P. 489-492 - septembre 2004 Retour au numéro
Article précédent
- Vitrectomy for a persisting macular fold in a case of resolved hypotony maculopathy
- Sarah E. Benson, Keith Barton, Zdenek J. Gregor
- Trypan blue induces apoptosis in human retinal pigment epithelial cells
- Kourous A. Rezai, Lili Farrokh-Siar, Elzbieta M. Gasyna, J.Terry Ernest
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?